Prot #R5459-RT-1956: A Noninterventional Extension Study for Patients Treated in Study R5459-RT-1944 with REGN5459 or REGN5458 (BCMA x CD3 Bispecific Antibodies) Who Receive a Kidney Transplant

Project: Research project

Project Details

StatusActive
Effective start/end date4/10/244/10/27

Funding

  • Parexel (Prot #R5459-RT-1956 // Prot #R5459-RT-1956)
  • Regeneron Pharmaceuticals, Inc. (Prot #R5459-RT-1956 // Prot #R5459-RT-1956)